APOLLO ENDOSURGERY, INC. APEN Cash Flow

Apollo endosurgery, inc. (APEN)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net loss
-10,256	-7,196	-8,658	-8,774	-2,804	-18,353	-9,759	-9,541	-8,134	-7,315	-4,902	-6,858	-8,217	-19,712	-5,933	-9,518	-6,004	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
955	952	956	1,048	1,104	2,268	2,337	2,329	2,358	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
955	952	956	1,048	1,104	2,268	2,337	2,329	2,358	2,457	2,383	2,478	2,399	2,345	2,362	2,310	2,075	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred financing costs
154	150	109	63	298	222	125	86	58	42	42	43	172	179	62	90	94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest
-356	-	-362	151	-3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest
-	-	-	-	-	-	-	-	92	102	101	108	284	9,422	782	1,368	1,745	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	801	0	-600	-250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for doubtful accounts receivable
77	3	110	136	-37	12	69	105	0	-	-	-	-	158	50	90	33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory impairment
0	82	40	0	40	20	106	159	102	493	30	89	80	453	82	3,215	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,226	-2,670	-2,772	-6,359	-3,169	-3,725	-3,300	-1,403	-2,529	-1,381	-1,249	-1,650	-1,101	-646	645	-3,968	1,130	1,371	-1,647
Stock based compensation
401	428	390	346	323	354	374	352	323	223	211	217	110	72	102	103	104	-230	236	214	251	236	295	386	317	206	227	208	193	146	195	149	108	173	137	143	247
Unrealized foreign exchange on intercompany payables
-2,240	1,164	-518	-1,368	936	-255	-412	-897	403	-399	518	-162	236	-263	-177	-669	-223	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Settlement gain
0	0	0	0	5,609	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	400	600	-200	-	-	550	200	300	300	400	1,900	-1,500	1,800	2,000	-1,700
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	119	71	70	49	68	63	35	34	32	87	42	112	27	25	21	76	28	15	21
Changes in operating assets and liabilities:
Accounts receivable
-1,430	222	-1,957	673	-790	1,250	-1,178	152	-62	-498	-600	2,672	-658	542	-1,614	546	952	-596	-675	-710	715	-1,331	745	-1,390	1,394	687	239	154	-5	-138	-269	-2,754	2,062	-541	1,006	-1,290	-13,230
Inventory
1,522	-1,914	383	157	502	-2,565	-1,449	-196	1,206	2,121	1,382	-139	-514	-1,038	1,435	3,804	-1,147	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
113	-199	166	-197	350	-125	-182	56	210	-63	-766	-250	131	555	82	-583	-381	561	-103	-133	17	-1,248	1,243	-27	153	31	66	-22	-90	21	156	-59	-143	-107	343	-27	-43
Accounts payable and accrued expenses
15	-2,149	-1,453	-68	1,618	1,743	727	-4,006	272	1,440	-1,540	3,923	916	755	1,125	5,669	-3,595	2,519	-566	-390	-1,050	969	-63	-306	501	92	1,166	527	-1,964	507	-24	-230	-1,092	2,112	33	-7	-910
Net cash used in operating activities
-6,263	-6,677	-6,218	-6,665	-6,062	-4,201	-2,703	-9,529	-6,686	-3,645	-4,139	-2,085	-3,451	-6,369	-1,796	13	-4,749	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Deferred contract revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-62	-62	-62	-62	-124	-124	-1,000	-1,845	-1,603	-887	-955	-1,060	-1,089	-677	-1,975	-782	-750	-750
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	6	7	7	7	4	4	4	-0	7	29	-6	-30	31	-42	54	-51	71	-34
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,666	-2,598	-4,554	-3,044	-5,327	-2,893	-3,921	-3,794	-2,504	-2,851	-3,999	-2,015	-2,118	590	-4,770	-1,373	-2,552	20	11,968
Purchases of property and equipment
272	339	89	265	112	-14	475	317	1,173	306	212	793	253	404	52	153	419	4,741	0	0	21	6	0	7	91	6	0	26	11	0	63	72	19	4	31	86	11
Purchases of intangibles and other assets
46	-6	82	34	65	176	348	286	120	154	90	152	177	344	184	442	367	1,812	59	67	78	121	112	98	98	74	86	111	73	39	42	60	47	77	200	40	36
Net cash used in investing activities
-318	1,667	-171	-281	-177	9,838	-823	-603	-1,293	-460	-302	-945	-430	-548	-236	-595	-786	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-59	-67	-100	-128	-112	-106	-189	-81	-86	-138	-85	-39	-105	-133	-66	-81	-232	-126	-48
Proceeds from sale of common stock and warrants, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-52	11,685	1,164	8,440	-	-	-	-	10,866	0	0	8,211	-	-	-	-
Proceeds from exercise of stock options
0	20	4	4	3	0	51	584	103	0	73	25	21	8	9	-3	39	75	0	2	45	0	0	0	0	12	0	1	1	-	-	-	-	0	0	28	5
Proceeds from long-term debt
0	-	0	0	35,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of deferred financing costs
206	120	1,516	92	1,129	47	0	0	353	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of long-term debt
0	0	0	0	21,668	10,000	2,500	0	0	0	0	0	7,000	11,220	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-206	-100	18,488	-88	12,206	-10,047	-2,449	22,441	-250	0	33,657	25	-6,979	17,572	9	-5,003	39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash
-95	55	-52	-29	18	-37	-16	-121	68	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash, cash equivalents and restricted cash
-6,882	-5,055	12,047	-7,063	5,985	-4,447	-5,991	12,188	-8,161	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash
-95	55	-52	-29	18	-37	-16	-121	68	24	43	11	53	-151	-1	51	5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash, cash equivalents and restricted cash
-6,882	-5,055	12,047	-7,063	5,985	-4,447	-5,991	12,188	-8,161	-4,081	29,259	-2,994	-10,807	10,504	-2,024	-5,534	-5,491	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment for restricted stock tax liability on net settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	12	70	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,426	1,846	45	-54	11,685	1,151	8,370	812	0	-42	1	10,656	0	0	8,211	0	0	28	5
Net cash used in operating activities.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,063	-2,591	-3,032	-4,082	8,600	-2,223	457	3,375	-1,455	-2,785	-78	11,926
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-300	-819	-4,608	-3,226	6,245	-1,847	4,259	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Cash paid for interest
814	836	881	593	1,160	1,037	939	910	889	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	909	1,057	2,097	1,392	1,392	910	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for income taxes
7	196	100	32	0	62	-6	28	14	96	141	19	18	-	-	-	-	47	0	0	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	1
Right-of-use assets recognized in exchange for new lease obligations (non-cash)
36	101	0	0	2,789	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of dividends on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	2,127	2,396	2,259	2,258	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-600	-250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	400	600	-200	-	-	550	200	300	300	400	1,900	-1,500	1,800	2,000	-1,700